Investors
A MESSAGE FROM OUR CEO
“We have excellent opportunities ahead of us, and we remain focused on delivering patient, company and shareholder value.”
-
April 30, 2024 RegulatoryChange in number of shares and votes in SynAct Pharma AB
-
April 30, 2024 RegulatoryNotice of annual general meeting in SynAct Pharma AB
SynAct Pharma AB published its year-end report for 2023 on February 23 at 07.30 CET.
Conference call and online presentation: the same day at 15.00 CET.